PHILADELPHIA, PA; June 5, 2024 – Quotient Sciences, the drug development and manufacturing accelerator, has announced changes to its operational leadership team for its Philadelphia, Pa. facilities. Marlene Leuenberger has joined as Vice President and General Manager of Quotient Sciences’ Philadelphia facilities.
Ms. Leuenberger is an established operations leader with over three decades of experience in the pharmaceuticals and consumer health industries with companies including Procter & Gamble, Wyeth Pharmaceuticals, and Novartis Consumer Health. Prior to joining Quotient Sciences, Marlene was Vice President of Operations and Site Head at Jubilant Cadista Pharmaceuticals in Salisbury, Maryland and General Manager at Catalent in Somerset, NJ. She holds a Bachelor of Science in chemical engineering from Clarkson University.
Together, Quotient Sciences’ facilities in Garnet Valley and Boothwyn, located just outside of Philadelphia, support small-molecule oral solid dose (OSD) formulation development and drug product manufacturing, with capabilities to support small batches for Phase I/II trials through late-phase manufacturing and commercial drug product supply.
“Our team in Philadelphia is pivotal to how we support our customers in delivering drug programs every day.” said Paul Ryan, Chief Operating Officer - Drug Substance & Drug Product at Quotient Sciences. “I’m looking forward to working with Marlene on a renewed commitment to operational excellence at our Philadelphia sites, as we continue to grow Quotient Sciences as a global leader and preferred CDMO/CRO partner for integrated drug development.”